pharma
AZ’s Tagrisso gets FDA nod in first-line EGFR-mutated lung cancer
April 19, 2018Sales and Marketing AstraZeneca, Cancer, EGFR-TKIs, NSCLC, Tagrisso, lung cancer, pharma
AstraZeneca has announced that its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib) has received approval from …
BenevolentAI financing round takes valuation to $2bn+
April 19, 2018Medical Communications BenevolentAI, biotech, drugs, pharma, pharmaceutical
BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued …
Novartis snatches Amgen and BMS veteran for CMO and Drug Development Head
April 19, 2018Medical Communications Amgen, BMS, Bristol-Myers Squibb, Novartis, appointment, pharma
Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, …
Merck KGaA finds consumer health buyer in P&G for €3.4bn
April 19, 2018Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical
Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …
EMA initiates divorce process from the UK’s MHRA
April 19, 2018Medical Communications EMA, UK government, biotech, brexit, drugs, pharma, pharmaceutical
The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to …
BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer
April 18, 2018Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma
The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …
EpiPen shortage hits UK and Canada hard, but not US
April 18, 2018Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical
Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
Amgen and Novartis’ Aimovig shines in migraine at Phase 3
April 18, 2018Research and Development Aimovig, Amgen, Novartis, migraine, pharma
Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …
Sanofi CFO set to step down this year
April 18, 2018Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical
After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …
All indications point to approval for cannabis-based therapy
April 17, 2018Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical
GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
Novartis to invest $100m in new malaria treatments
April 17, 2018Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma
Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …
FDA flip-flops on Alkermes’ drug application
April 17, 2018Manufacturing and Production, Sales and Marketing Alkermes, FDA, biotech, drugs, pharma, pharmaceutical
Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the …
Amazon puts selling pharmaceuticals plan on back-burner
April 17, 2018Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy
Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …
Keytruda success continues, beating Opdivo in lung cancer survival
April 17, 2018Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
Frequency Therapeutics hires industry vet
April 16, 2018Manufacturing and Production, Medical Communications Frequency Therapeutics, biotech, drugs, pharma, pharmaceutical
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
